Naloxone Hydrochloride Injection, Usp, Auto-injector Injection, Solution
Product Images NDC 60842-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride Injection, Usp, Auto-injector (NDC 60842-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kaleo, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Naloxone Figure 1)

FDA Label Image

Auto-injectors Label (Naloxone Figure 10)

Auto-injectors Label (Naloxone Figure 10)
Not available. The text appears to be garbled and does not provide relevant information.*
FDA Label Image

Device Label (Naloxone Figure 11)

Device Label (Naloxone Figure 11)
This is a description of an auto-injector containing Naloxone HCI used for opioid emergencies. The auto-injector contains 10mg and is single-dose. The injector includes a viewing window and two ends, a black end, and a red end, where the needle end is present. During the use of the auto-injector, one needs to place the black end against the outer thigh or behind, press firmly for 5 seconds, and listen carefully for a clicking and hissing sound. If the drug appears cloudy, replace it. The auto-injector is for Rx only. The label includes the lot number, expiration date, UDI number, and the drug's name.*
FDA Label Image

Outer Case Label (Naloxone Figure 12)

Outer Case Label (Naloxone Figure 12)
This is a description of a Naloxone HCl Injection auto-injector device that is intended to be used in emergency situations for adults and children aged 12 and above. The text provides instructions to pull the device from its case, replace it if the drug is cloudy or contains particles, and not freeze it. The viewing window allows the user to see the contents of the device. The device contains 10 mg of Naloxone HCl Injection, USP and should be stored between 15°C-25°C (59°F-77°F), with excursions permitted between 4°C and 40°C (39°F and 104°F). The device is single-dose and manufactured for kaleo Inc., with instructions for use, lot, and expiration date found on the device.*
FDA Label Image

Figure1a (Naloxone Figure 2)

Figure1a (Naloxone Figure 2)
This appears to be a data table with the header "Mean Naloxane Concentration (ng/mL)" and two columns labeled "NALOXONE HYDROCHLORIDE injection 2 mg" and "NALOXONE HYDROCHLORIDE injection 10 mg". There is also a row labeled "Time PostDose (h)" suggesting that this data represents measurements taken at different time intervals after the administration of naloxone hydrochloride at the given doses.*
FDA Label Image

Figure1b (Naloxone Figure 3)

Figure1b (Naloxone Figure 3)
This appears to be a data table for two types of naloxone hydrochloride injections with varying dosages, showing the mean concentration of naloxone over time post-dose. The table may be part of a larger research study or drug trial.*
FDA Label Image

Figure A (Naloxone Figure 4)

Figure A (Naloxone Figure 4)
This is a description of NALOXONE HYDROCHLORIDE injection auto-injector, which is used to treat opioid emergencies in adults and children over 12 years of age. The injector contains a single dose of 10mg Naloxone HCI Injection USP and can be administered via intramuscular or subcutaneous injection. Instructions for use, as well as the lot and expiration dates can be found on the device. The outer case needs to be removed to access the injector.*
FDA Label Image

Figure A (Naloxone Figure 5)

FDA Label Image

Figure A (Naloxone Figure 6)

FDA Label Image

Figure A (Naloxone Figure 7)

FDA Label Image

Figure A (Naloxone Figure 8)

Figure A (Naloxone Figure 8)
The text describes the features of a medication called Naloxone HCI Injection, USP. It has a viewing window with a red indicator, and the base is locked with the needle retracted. It is unclear from this text what medical condition it is used to treat.*
FDA Label Image

Figure A (Naloxone Figure 9)

Figure A (Naloxone Figure 9)
This appears to be a section of a document containing a date format (MM-YYYY) and a code or reference number (123456789012) followed by a lot number (1234567890). It does not provide enough context to determine the purpose or meaning of this information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.